Preclinical Study Evaluates Feeder-Free Expansion Method for Tumor-Infiltrating Lymphocyte Therapy

A preclinical study evaluates a feeder-free expansion method for TIL therapy, aiming to reduce IL-2 reliance and improve safety in solid tumor immunotherapy.